Editor's Correspondence |

The Variable Effects of Whole-Leaf Digitalis Is a Paradigm of the Glycemic Effects of Ginseng—Reply

Vladimir Vuksan, PhD; John L. Sievenpiper, MSc
Arch Intern Med. 2000;160(21):3330-3331. doi:.
Text Size: A A A
Published online


In reply

Ritter and Dembicki in their letter and Cheng in his identify very important points of discussion. One concern was that some of the confounding variables inherent in the testing of plant-based medicines were not controlled in our study.1 Another was that some components of ginseng might interact with various drugs, resulting in undesirable outcomes.

Although the species (American ginseng [Panax quinquefolius L]), plant part (root), age (4 years), preparation (dried ground root), manufacturer lot (same), and growing location (Ontario) of the ginseng used in our study were controlled, Ritter and Dembicki are correct that we neglected to characterize the active components. Several active ginseng components that may affect carbohydrate metabolism have been implicated in data from animal studies. These include ginsenosides (saponins), the main markers used for species identification and standardization.2 Other components include panaxans (peptidoglycans) and the water- and methanol-soluble fractions of Panax ginseng CA Meyer, DPG-3-2, and EPG-3-2, respectively.2 Because of the documented variability of these components among and within ginseng species,3 it is unclear whether the glycemic-lowering effect of the ginseng in our study would occur for other species or even for related American ginseng products. We therefore have addressed the need for further characterization of active components in subsequent ginseng studies.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics